We may or may not be out of the woods, but focusing on the short-term performance of stocks is not the best strategy.

What’s powering a $26.28 billion opportunity? The global ophthalmology drugs market, valued at US$18.34 billion in 2024 stood ...

Moderna has a deep pipeline of promising mRNA candidates that stand to boost business. Regeneron is looking at label expansions for its main product as well as clinical progress elsewhere. Here ...

Eylea has become the leading franchise in wet AMD and other ophthalmology markets, and Eylea HD with longer dosing intervals maintains a competitive profile with Roche's Vabysmo.

Avastin costs around £28 per injection when used off-label as an intravitreal injection for AMD, which compares to a cost of £816 for Eylea and £551 for Lucentis, according to the judicial ...

Over the last 30 years, Diddy's label Bad Boy Records has released music from artists like Machine Gun Kelly, Janelle Monaé, and Yung Joc.

Outlook Therapeutics' Lytenava is the first ophthalmic formulation of bevacizumab to be cleared for use by NICE for use in the NHS for wet AMD.

New Products & Services News releases reporting new products and services announcements are posted as available. Various industries are represented.